Display Settings:


Send to:

Choose Destination
See comment in PubMed Commons below
Arch Otolaryngol Head Neck Surg. 2003 Dec;129(12):1322-6.

Significance of c-Myc and Bcl-2 protein expression in nasopharyngeal carcinoma.

Author information

  • 1Department of Otolaryngology, Beifang Hospital of Shenyang, 83 Wenhua Road, Shenhe District, Shenyang City, Liaoning Province, People's Republic of China 110015. chanpingwang@yahoo.ca



To investigate the relationship between oncogene protein expression and nasopharyngeal carcinoma outcome.


Tumor samples from 51 patients with nasopharyngeal carcinoma were analyzed by immunohistochemical staining for expression of Bcl-2 and c-Myc protein before irradiation. Five-year follow-up data were available.


Thirty-one (61%) of 51 tumors expressed Bcl-2 protein, and 29 (57%) of 51 tumors expressed c-Myc protein. In the Bcl-2+ group, 20 (65%) and 19 (61%) of 31 patients experienced recurrence or died, respectively, whereas only 7 (35%) and 5 (25%) of 20 patients with Bcl-2- tumors did so. On the other hand, patients with c-Myc+ tumors had lower recurrence and death rates (38% [11/29] and 34% [10/29], respectively) than those with c-Myc- tumors (73% [16/22] and 64% [14/22], respectively). A statistically significant association was confirmed between Bcl-2 and c-Myc positivity and patient outcome.


Expression of Bcl-2 and c-Myc protein seems to be a useful marker to reflect irradiation response and to predict illness condition and patient outcome.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Silverchair Information Systems
    Loading ...
    Write to the Help Desk